Adagio Medical (ADGM) Stock Price, News & Analysis

Company Overview

Adagio Medical, Inc. is a medical-device company focused on developing catheter-based technologies for the treatment of cardiac arrhythmias, including atrial fibrillation. The company’s work is centered on cardiac ablation, a procedure that uses energy to create targeted lesions in heart tissue responsible for abnormal electrical signals.

Its lead technology is the iCLAS system, an integrated cardiac liquid ablation platform designed to support cardiac ablation procedures using ultra-low-temperature cryoablation and pulsed-field ablation capabilities. The system is intended to help physicians treat arrhythmias through catheter-based procedures, with potential applications that include persistent atrial fibrillation and other complex rhythm disorders. Product availability and regulatory authorization may vary by geography and indication.

Adagio Medical was founded in 2011 and is based in Laguna Hills, California. The company has focused primarily on research, clinical development and regulatory advancement of its ablation platform, serving the global electrophysiology and cardiovascular-care markets. Its leadership has included founder and Chief Executive Officer Olav Bergheim.

Key Stats

• Today's Range: $0.48 to $0.52
• 50-Day Range: $0.37 to $0.80
• 52-Week Range: $0.36 to $2.58
• Volume: 97,110 shs
• Average Volume: 221,870 shs
• Market Capitalization: $10.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $3.50
• Consensus Rating: Hold

Adagio Medical Stock Analysis - MarketRank™

Adagio Medical scored higher than 47% of companies evaluated by MarketBeat, and ranked 446th out of 905 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Hold

Consensus Rating

Adagio Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Adagio Medical has a consensus price target of $3.50, representing about 625.4% upside from its current price of $0.48.

Amount of Analyst Coverage

Adagio Medical has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Decreasing

Earnings Growth

Earnings for Adagio Medical are expected to decrease in the coming year, from ($1.25) to ($1.75) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Adagio Medical is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Adagio Medical is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Adagio Medical has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.27% of the float of Adagio Medical has been sold short.

Short Interest Ratio / Days to Cover

Adagio Medical has a short interest ratio ("days to cover") of 0.77, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Adagio Medical has recently decreased by 20.35%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Adagio Medical does not currently pay a dividend.

Dividend Growth

Adagio Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Adagio Medical this week, compared to 2 articles on an average week.

MarketBeat Follows

Only 1 people have added Adagio Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Adagio Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

7.81% of the stock of Adagio Medical is held by insiders.

Percentage Held by Institutions

48.08% of the stock of Adagio Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/11/2026
• Today: 9/18/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:ADGM
• Previous Symbol: NASDAQ:ADGM
• CIK: 2006986
• Web: adagiomedical.com
• Phone: (949) 348-1188
• Fax: N/A
• Employees: 41
• Year Founded: 2023

Price Target and Rating

• Average Price Target for Adagio Medical: $3.50
• High Price Target: $4.00
• Low Price Target: $3.00
• Potential Upside/Downside: +625.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.48)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$25.08 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -661.85%
• Return on Assets: -73.35%

Debt

• Debt-to-Equity Ratio: 4.00
• Current Ratio: 1.41
• Quick Ratio: 1.15

Sales & Book Value

• Annual Sales: $600 thousand
• Price / Sales: 17.86
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.59 per share
• Price / Book: 0.82

Miscellaneous

• Outstanding Shares: 22,210,000
• Free Float: 20,475,000
• Market Cap: $10.72 million
• Optionable: N/A
• Beta: -0.09